In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Antti Äärelä und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Turku, FI-20500 Turku, Finland. Hauptthemen laut MEDLINE: Fullerenes, Nucleic Acids, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Turun Yliopistos??ti?, Turun Yliopisto, Academy of Finland.
Abstract (Originalsprache)
18F-Labeled [60]fullerene-based molecular spherical nucleic acids (MSNAs), consisting of a human epidermal growth factor receptor 2 (HER2) mRNA antisense oligonucleotide sequence with a native phosphodiester and phosphorothioate backbone, were synthesized, site-specifically labeled with a positron emitting fluorine-18 and intravenously administrated via tail vein to HER2 expressing HCC1954 tumor-bearing mice. The biodistribution of the MSNAs was monitored in vivo by positron emission tomography/computed tomography (PET/CT) imaging. MSNA with a native phosphodiester backbone (MSNA-PO) was prone to rapid nuclease-mediated degradation, whereas the corresponding phosphorothioate analogue (MSNA-PS) with improved enzymatic stability showed an interesting biodistribution profile in vivo. One hour after the injection, majority of the radioactivity was observed in spleen and liver but also in blood with an average tumor-to-muscle ratio of 2. The prolonged radioactivity in blood circulation may open possibilities to the targeted delivery of the MSNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland.
- Research and Development, Orion Pharma, FI-20380 Turku, Finland.
- Turku PET Centre, University of Turku, FI-20520 Turku, Finland.
- Turku Center for Disease Modeling, University of Turku, FI-20520 Turku Finland.
- Accelerator Laboratory, Åbo Akademi University, FI-20520 Turku, Finland.
- Turku PET Centre, Turku University Hospital, FI-20520 Turku, Finland.
ORCID-Profile: Imran Iqbal, Anu J Airaksinen, Pasi Virta
Förderung
- Turun Yliopistos??ti?
- Turun Yliopisto
- Academy of Finland
- Jane ja Aatos Erkon S??ti?
- Business Finland
Zitieren
APA
Äärelä, A., Auchynnikava, T., Moisio, O., Liljenbäck, H., Andriana, P., Iqbal, I., Lehtimäki, J., Rajander, J., Salo, H., Roivainen, A., Airaksinen, A. J., & Virta, P. (2023). In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00370
Vancouver
Äärelä A, Auchynnikava T, Moisio O, Liljenbäck H, Andriana P, Iqbal I, et al. In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00370
BibTeX
@article{rel2023,
author = {Äärelä, Antti and Auchynnikava, Tatsiana and Moisio, Olli and Liljenbäck, Heidi and Andriana, Putri and Iqbal, Imran and Lehtimäki, Jyrki and Rajander, Johan and Salo, Harri and Roivainen, Anne and Airaksinen, Anu J and Virta, Pasi},
title = {In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00370}
}
EUVIMED